In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 4th, 2005 | 29 | No |
Popular Name: Cefuroxime sodium Cefuroxime sodium
Find On: PubMed — Wikipedia — Google
CAS Numbers: 55268-75-2 , 555268-75-2 , 56238-63-2 , 69088-15-9 , [55268-75-2] , [56238-63-2]
56238-63-2; C08108; Cefuroxime sodium
56238-63-2; CXM; Cefuroxime sodium (JAN/USP); D00915; Zinacef (TN)
Cefuroxim;Cefuroxime [USAN:BAN:INN];Cefuroximo [INN-Spanish];Cefuroximum [INN-Latin]
CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER
Cefuroxime for Injection and Dextrose for Injection in Duplex Container
Cefuroxime sodium [USAN:BAN:JAN]
Cefuroxime, Antibiotic for Culture Media Use Only
cefuroxime; cefuroximo; cefuroximum
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | -0.98 | 2.31 | -68.98 | 3 | 12 | -1 | 177 | 423.383 | 8 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
MP | 176 - 178 | Enamine Building Blocks |
MP | 176...178 | Enamine Building Blocks |
ALOGPS_SOLUBILITY | 2.84e-01 g/l | DrugBank-approved |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 98% | APIChem |
Indications | antibiotic | KeyOrganics Bioactives |
Patent Database Links | EP1359153; EP1452533; EP1702921; EP1724273; EP1815846; EP1829527; EP1829528; GB2157565; US2006235023; US2006258636; US2007202051; US2007202077; US2007212340; US2008255073; US2008255200; WO2005009948; WO2005020894; WO2006005137; WO2007089745; WO2007100902 | ChEBI |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Enamine; NCC_SUPPLIER_STRUCTURE_ID : 241392054 | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Enamine; SUPPLIER_STRUCTURE_ID: 241392054 | NIH Clinical Collection via PubChem |